Работы, цитирующие эту работу

Работ: 4

Работа: Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection

1. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

   Parvati Nair, T. Hasan, K. K. Zaw +9

   СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2022Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.281624

2. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2019Цитирований: 1

   ABIABI:AkademIndex/openalex/2019.article.000020

3. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

   M. Bonnet, Mathieu Bastard, Philipp du Cros +9

   СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2015Цитирований: 0

   ABIABI:AkademIndex/openalex/2015.article.000040

4. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

   Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

   СтатьяTuberculosis Research and EpidemiologyPLoS ONE2018Цитирований: 0

   ABIABI:AkademIndex/openalex/2018.article.000060